The main purpose of this study is to explore the safety and tolerability of LY3471851 in healthy Japanese and Caucasian participants. The study will also estimate how much LY3471851 gets into the blood stream and how long it takes the body to remove it. The study is expected to last about 7 weeks for each participant.

Inclusion Criteria:

• Are healthy males or females, as determined by medical history and physical examination
• Are first generation Japanese or are Caucasian
• Have a body mass index (BMI) of 18.0 to 32.0 kilograms per square meter (kg/m²), inclusive, at the time of screening

Exclusion Criteria:

• Are currently enrolled in a clinical study involving an investigational product (IP) or any other type of medical research judged not to be scientifically or medically compatible with this study
• Have an abnormal blood pressure and/or pulse rate as determined by the investigator
• Regularly use known drugs of abuse and/or show positive findings on drug screening
• Are immunocompromised per investigator judgment